- About GRP
- Resource Center
- RI Platform
- Contact Us
The following four FDA programs are intended to facilitate and expedite development and review of new drugs to address unmet medical need in the treatment of a serious or life-threatening condition: fast track designation, breakthrough therapy designation, accelerated approval, and priority review designation.
Copyright ©2023 Global Regulatory Partners